Journal Home
Search for

Volume 141, Issue 2, Pages 127-130 (December 2008)


View previous. 9 of 25 View next.

Adverse mood effects of combined oral contraceptives in relation to personality traits

Anna Borgströma, Viveca Odlindab, Lisa Ekseliusc, Inger Sundström-PoromaaaCorresponding Author Informationemail address

Received 27 March 2008; received in revised form 23 April 2008; accepted 3 July 2008. published online 13 August 2008.

Abstract 

Objective

Mood symptoms, such as depressed mood, anxiety and increased irritability, remain one of the major reasons for discontinuation of combined oral contraceptive (COC) pills. The aim of this study was to compare personality traits in women with ongoing or previous use of COCs and different experiences from these compounds with respect to adverse mood symptoms.

Study design

Thirty women currently on COCs with no reports of adverse mood symptoms, 28 women currently on COCs and experiencing mood-related side effects, 27 women who had discontinued COC use for reasons other than adverse mood symptoms and 33 women who had discontinued COC use due to adverse mood effects were included. All participants were asked to fill out the Swedish universities Scales of Personality (SSP) to assess different personality traits.

Results

The women who were experiencing mood-related side effects on their current COC use exhibited higher scores on the somatic anxiety and stress susceptibility traits as compared to the women who did not experience any mood-related side effects from their current COCs. Women who had discontinued COC treatment because of adverse mood effects had higher scores of detachment and mistrust compared to women who had discontinued COC for reasons unrelated to mood effects.

Conclusion

Higher scores on specific personality traits such as somatic anxiety and stress susceptibility are found in women with ongoing experience of adverse mood symptoms from COC. Higher scores of mistrust and detachment are more common among women who have discontinued COC treatment due to adverse mood effects.

a Department of Women's and Children's Health, Uppsala University, SE-751 85 Uppsala, Sweden

b Medical Products Agency, Uppsala, Sweden

c Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden

Corresponding Author InformationCorresponding author. Tel.: +46 18 611 57 64; fax: +46 18 55 97 75.

PII: S0301-2115(08)00292-3

doi:10.1016/j.ejogrb.2008.07.018


View previous. 9 of 25 View next.